Hemmer, Bernhard
Mühlau, Mark
Article History
First Online: 20 January 2017
Competing interests
: B.H. has served on scientific advisory boards for Novartis, Bayer Schering, F. Hoffmann-La Roche, AllergyCare and Genentech. He has received honoraria for lectures from Teva Pharmaceutical Industries, Biogen Idec, Medimmune, Merck Serono and F. Hoffmann-La Roche, and has received research support from Chugai Pharmaceuticals and F. Hoffmann-La Roche. He has filed two patents, one for the detection of antibodies and T cells against KIR4.1 in a subpopulation of multiple sclerosis patients, and one for genetic determinants of neutralizing antibodies to IFNβ. M.M. has received research support from Merck Serono and Novartis.